Clostridium difficile in an oncology unit 981 bowel mucosal damage resulting in diarrhoea. It is important that diarrhoea is not accepted as a normal symptom of cancer chemotherapy and that stool specimens are sent for full bacteriological and viral investigations including examination for the presence of C difficile and its toxin. Relapse after the discontinuation of treatment with vancomycin, metronidazole, or bacitracin has been reported with incidences ranging from 5% to 59%.5 In the present series, the symptomatic relapse rate was 38%.
There now seems little doubt that C difficile infection is a communicable disease, which may cause outbreaks of infection in hospital.2 3 Patients with diarrhoea known or suspected to be due to C difficile should be isolated and 'barrier-nursed' in the same way as patients with other recognised gastrointestinal pathogens. The low incidence of asymptomatic carriage detection in this study suggests that screening is probably not worthwhile as a routine preventive measure except during an outbreak. Antibiotic policies should be reviewed if an outbreak occurs.
It is possible that the outbreak could have been aborted if control measures had been commenced sooner. Recognition that an outbreak is occurring is therefore vital, particularly in units which already have a low 'background' incidence of infection.
Therefore we suggest that paediatric oncology units should monitor the number of cases of C difficile infection and if there is any evidence of an increasing incidence control measures should be started.
With early treatment severe life threatening illness may be prevented. 
Results
The changes in mean lower leg length, standing height, weight, and soft tissue thickness are shown in fig 1. It can be seen that there was consistent growth on days free of steroid, followed by a smaller shortening on treatment days. This pattern was maintained on and after the days when steroids were administered consecutively in the final week. This pattern can be quantified by comparing the changes in length observed from 'no treatment to treatment' days with 'treatment to no treatment' days and is significant (t=3-62; 13 df; p<O-005) (fig 2) . The changes in weight tended to parallel the changes in lower leg length (on 11 out of 15 occasions) but the association was not significant (t=1.53; 13 df; p<02). Although the total soft tissue thickness varied from day to day, the changes were not significant and tended to oppose the length changes, supporting the observation that true lengthening of the lower leg occurred on steroid free days. 
Discussion
The knemometer provides a valuable means of observing biological phenomena related to short term, and ultra short term growth changes of the lower leg. The magnitude of the observed fluctuations in lower leg length in this case are well within the observed capabilities of the apparatus.2 The mechanism of the growth inhibition due to steroid administration is uncertain but is probably secondary to a peripheral blocking of the action of growth hormone. 6 We postulate that the observed loss of length on days when steroids were administered is due to postural compression of non-growing cartilage and bone and is similar to the loss of length seen during illness or catabolic stress that we have previously described.2 The observed differences in lower leg length probably do represent true changes in bone length rather than a soft tissue effect and could represent the first direct observation of the growth sparing effect of alternate day steroid regimes.
We thank Mrs M Pickering for performing the auxological observations.
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Community and Continuing Care Unit, Islington Health Authority, London SUMMARY Rubella vaccination was offered to a cohort of schoolgirls 14 years and over whose immune state was unknown. This increased the percentage vaccinated or known to be immune from 86% to 90%. It is recommended that rubella vaccination should be offered to girls until they leave school at 16 years of age.
The uptake of rubella vaccine by schoolgirls has increased since 1976 but in most areas is still below 90%.1 In inner city areas absenteeism, failure to return consent forms, intercurrent illness, parental refusal, and desire to attend their own general practitioner, have a negative influence on vaccine uptake.2 High mobility of the population and administrative difficulties within schools are additional factors. The schoolgirl rubella vaccination programme is
